Human KCC2 Protein Expression in HEK293 Cells
Corresponding Organization :
Other organizations : Institut de génétique et de biologie moléculaire et cellulaire, Inserm, Université de Strasbourg, Centre National de la Recherche Scientifique, Institut de Neurobiologie de la Méditerranée, AstraZeneca (United Kingdom), Tufts University, AstraZeneca (United States), AstraZeneca (Sweden), Institut Paoli-Calmettes
Variable analysis
- KCC2 constructs transfected into HEK293 cells
- Suspension Expi293F cells transfected with KCC2 plasmid DNA
- Expression of human KCC2 confirmed by Western-blot
- Culture media (DMEM with 10% FBS and 1% GlutaMAX)
- Transfection conditions (DNA and PEIMax pre-incubated in E293F media for 15 minutes)
- Incubation conditions (5% CO2 at 37 °C and 140 rpm)
- Mouse KCC2 expressed in HEK293 and N2a cells as previously described
- Rabbit anti-KCC2 as primary antibody (Sigma/Millipore #07-432) used for Western-blot
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!